Skip to the main content.
HUB of
Biotherapeutic
Intelligence™
Protein Production
Overview
 
Online Store

Explore now

See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
Applications
Insights
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

In the News

Contact Us

ImmunoPrecise Exhibiting at Discovery on Target in Boston, MA, on September 16-19

ImmunoPrecise Antibodies will participate in the 17th Annual Discovery on Target (DOT) being held Boston, MA September 16-19. With over 1,300 attendees and a variety of keynote speakers, training seminars, short courses, roundtables, and networking functions, DOT is said to be the industry’s preeminent event on novel drug target and technologies.

Jennifer Bath, Ph.D., and Barry Duplantis, Ph.D., will be available at booth 308 to discuss with attendees how ImmunoPrecise Antibodies’ broad range of products and services, including our B cell Select™ antibody discovery platform, can streamline and accelerate their therapeutic antibody development efforts. Attendees can schedule a meeting with Jennifer or Barry by emailing Barry at bduplantis@immunoprecise.com or by using the Brella networking app.

Register for IPA Updates

By clicking submit below, you agree that IPA may store and process your personal information to send you email updates. You can find further information in our Privacy Policy.

Connect with IPA